U.S. Markets closed

Astellas Pharma Inc. (ALPMF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
11.890.00 (0.00%)
At close: 2:30PM EDT
People also watch
ALPMYTKPHFESALFESALYTKPYY
Full screen
Previous Close11.89
Open0.00
Bid0.00 x
Ask0.00 x
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume27,615
Market Cap24.57B
BetaN/A
PE Ratio (TTM)12.87
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Capital Cube29 days ago

    ETFs with exposure to Astellas Pharma, Inc. : June 28, 2017

    Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Astellas Pharma, Inc. Here are 5 ETFs with the largest exposure to ALPMF-US. Comparing the performance and risk of Astellas Pharma, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more (Read more...)

  • Astellas Pharma, Inc. :ALPMF-US: Earnings Analysis: Q4, 2017 By the Numbers : June 21, 2017
    Capital Cubelast month

    Astellas Pharma, Inc. :ALPMF-US: Earnings Analysis: Q4, 2017 By the Numbers : June 21, 2017

    Categories: Yahoo FinanceGet free summary analysis Astellas Pharma, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Astellas Pharma, Inc. – OncoMed Pharmaceuticals, Inc., Omeros Corporation and Ohr Pharmaceutical, Inc. (OMED-US, OMER-US and OHRP-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • Capital Cube3 months ago

    Astellas Pharma, Inc. – Value Analysis (US OTC:ALPMF) : May 1, 2017

    Categories: Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Astellas Pharma, Inc. a score of 80. Our analysis is based on comparing Astellas Pharma, Inc. with the following peers – OncoMed Pharmaceuticals, Inc., Omeros Corporation, Onconova Therapeutics Inc. and Omni Bio Pharmaceutical, Inc. (OMED-US, OMER-US, ONTX-US and OMBP-US). Investment Outlook Astellas Pharma, Inc. has a fundamental ... Read more (Read more...)